IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT

Clinical trial NCT03696537 · TERMINATED

Trial details

NCT number: NCT03696537
Sponsor: Naoyuki G. Saito, M.D., Ph.D.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Chronic Myeloid Leukemia Acute Lymphocytic Leukemia Myelodysplastic Syndromes

Start date: 2018-08-29
Primary completion: 2020-07-08
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.